GoodRx vs Kin Meds
GoodRx and Kin Meds both sell tirzepatide and orforglipron; this is how their prices, coverage and records differ.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
If you are choosing between GoodRx and Kin Meds, price alone will not settle it. Both prescribe tirzepatide and orforglipron, so moving from one to the other would not change your drug. GoodRx leads our six-part score, 6.9 to 6.5. One of the two has an FDA warning letter on record, covered below.
GoodRx vs Kin Meds price
GoodRx and Kin Meds start at the same figure, $149 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.
Drug by drug: Tirzepatide is cheaper at Kin Meds ($149 a month vs $299 a month); orforglipron costs the same at both, $149 a month.
Medications and formats
Both sell tirzepatide and orforglipron; only Kin Meds lists semaglutide.
On format, GoodRx prices brand-name pens, while Kin Meds prices compounded injections and brand-name pens.
Where each one treats patients
GoodRx lists 50 states, and Kin Meds does not publish where it ships.
Pricing
GoodRx
Kin Meds
$53 off first order, applied automatically at checkout per kinmeds.com/glp1-discount ('Save $53 on first order -Discount applied at checkout')
$53 off first order, auto-applied; discount page quotes starting dose 'as low as $49/week' first month
Kin Meds advertises "Starting at $149/mo" for Wegovy injection, Wegovy pill, Zepbound KwikPen, Zepbound vial and Foundayo alike. The price carries a footnote marker, but the footnote itself is missing from the site, so its conditions are unstated. Compounded semaglutide is $199 and tirzepatide $249.
Entry pricing — likely insured/savings-card tier; cash-pay LillyDirect vials run $299-$449/mo
Matches the LillyDirect $149/mo starter cash price for Foundayo
What each price covers
Neither GoodRx nor Kin Meds spells out what its price covers, so ask whether the visit, the drug and shipping are all in the monthly figure.
Where each one scores higher
Overall, GoodRx scores 6.9 and Kin Meds 6.5 out of 10.
GoodRx is stronger on trust & safety (6.0 vs 3.5) and accessibility (10.0 vs 5.0).
Kin Meds is stronger on user experience (8.0 vs 5.0).
Value, effectiveness and support are within half a point.
GoodRx
6.9/10
Kin Meds
6.5/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Kin Meds a warning letter dated February 20, 2026 (letter 721450), and it is still open.
GoodRx has no FDA warning letter on record with us.
Features & Coverage
| Feature | GoodRx | Kin Meds |
|---|---|---|
| Starting Price | $149/mo | $149/mo |
| Features | 6 features | ✓8 features |
| States Available | 50 | Not disclosed |
| Compounded | — | ✓ Yes |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | ✓None | 1 letter |
About GoodRx
GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform. It publishes self-pay discount pricing on brand-name GLP-1 medications, with Foundayo (orforglipron) starting at $149/month and the Zepbound KwikPen (tirzepatide) starting at $299/month, redeemable at 70,000+ pharmacies nationwide. It also operates GoodRx Care, a telehealth arm that prescribes GLP-1s with online visits starting at $39.
Read our full GoodRx review →About Kin Meds
Kin Meds starts compounded semaglutide at $199/mo and compounded tirzepatide at $249/mo, and carries brand-name FDA-approved options including Wegovy injection and pill, Zepbound and Foundayo from $149/mo. It is LegitScript-verified. Beyond weight loss the account also covers Sermorelin, NAD+, glutathione, TRT, hair, skin and sexual health, so members can run several protocols in one place.
Read our full Kin Meds review →Pros & Cons
GoodRx
What we like
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Tirzepatide costs $299 a month, 76% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Serves all 50 states
- We found no FDA warning letters issued to GoodRx
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Kin Meds
What we like
- Semaglutide costs $149 a month, 85% below the $990 median for brand-name semaglutide across the sellers we compare
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued Kin Meds a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
GoodRx wins this one, 6.9 to 6.5, above all for oral orforglipron alongside the injectables. Kin Meds fits better if oral orforglipron alongside the injectables is your priority.
Choose GoodRx if…
You want oral orforglipron alongside the injectables and an opening price near $149 a month.
Choose Kin Meds if…
You want oral orforglipron alongside the injectables and an opening price near $149 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Collective
Flat any-dose pricing, if you can absorb a $199 annual membership on top
From $59/mo
Get started →Found
Tirzepatide at $169/month, 37% below the typical price
From $149/mo
Get started →Breeze Meds
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $199/mo
Get started →GoodRx vs Kin Meds: FAQ
Close alternatives to GoodRx and Kin Meds
- GoodRx vs Found
- GoodRx vs PrideRx
- GoodRx vs PreventiveMD
- Kin Meds vs Found
- Kin Meds vs PreventiveMD
- Kin Meds vs Sesame Care
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.